Related Experiment Video
Updated: Feb 15, 2026

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
Published on: June 28, 2021
Abstract:
The HIF2α antagonist PT2385 achieved responses in 14% of patients with heavily pretreated ccRCC.
Insights
The HIF2α antagonist PT2385 showed promise in treating advanced kidney cancer. It achieved responses in 14% of patients with heavily pretreated clear cell renal cell carcinoma (ccRCC).
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Clear cell renal cell carcinoma (ccRCC) is an aggressive cancer.
- Hypoxia-inducible factor 2-alpha (HIF2α) is a key driver in ccRCC progression.
- Novel therapeutic targets are needed for patients with advanced or refractory disease.
Purpose of the Study:
- To evaluate the efficacy of PT2385, a novel HIF2α antagonist, in patients with heavily pretreated ccRCC.
- To assess the safety and tolerability profile of PT2385 in this patient population.
Main Methods:
- A clinical trial was conducted involving patients with advanced ccRCC.
- Patients received PT2385 as a treatment.
- Response rates and adverse events were meticulously recorded.
Main Results:
- PT2385 demonstrated clinical activity, achieving objective responses in 14% of heavily pretreated ccRCC patients.
- The drug was generally well-tolerated, with a manageable safety profile.
Conclusions:
- HIF2α inhibition with PT2385 represents a potential therapeutic strategy for advanced ccRCC.
- Further investigation is warranted to optimize the use of PT2385 in kidney cancer treatment.
More Related Videos
08:08Antimicrobial Characterization of Advanced Materials for Bioengineering Applications
Published on: August 4, 2018
09:00Author Spotlight: Validation of SICOLE-R for Assessing Cognitive and Reading Skills in Spanish-Speaking Children and Its Role in Personalized Education
Published on: August 16, 2024
Related Concept Videos
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Extraction: Advanced Methods
Sample Preparation for Analysis: Advanced Techniques
Acid digestion with strong acids is commonly used to dissolve inorganic materials that are insoluble (do not dissolve) in water. This method can be useful for...
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques